John R. Rubin

3.7k total citations
77 papers, 2.9k citations indexed

About

John R. Rubin is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, John R. Rubin has authored 77 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 25 papers in Organic Chemistry and 23 papers in Oncology. Recurrent topics in John R. Rubin's work include RNA and protein synthesis mechanisms (14 papers), Chemical Synthesis and Analysis (13 papers) and Peptidase Inhibition and Analysis (10 papers). John R. Rubin is often cited by papers focused on RNA and protein synthesis mechanisms (14 papers), Chemical Synthesis and Analysis (13 papers) and Peptidase Inhibition and Analysis (10 papers). John R. Rubin collaborates with scholars based in United States, United Kingdom and New Zealand. John R. Rubin's co-authors include M. Sundaralingam, Debra R. Holland, Mark E. Snow, Charles O. Rock, Richard J. Heath, Tim Brennan, Raymond S. Brown, H. Guilley, G.G. Brownlee and A. Simoncsits and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

John R. Rubin

77 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Rubin United States 25 1.7k 956 382 260 260 77 2.9k
Keith Rose Switzerland 31 2.2k 1.3× 637 0.7× 365 1.0× 88 0.3× 373 1.4× 98 3.3k
C T Walsh United States 30 1.8k 1.1× 269 0.3× 284 0.7× 349 1.3× 330 1.3× 32 2.8k
Michael J. Kelso Australia 30 1.6k 0.9× 715 0.7× 491 1.3× 241 0.9× 557 2.1× 82 3.2k
Cai‐Guang Yang China 40 4.3k 2.6× 1.7k 1.7× 368 1.0× 265 1.0× 170 0.7× 115 6.4k
Glenn E. Dale Switzerland 35 1.6k 1.0× 287 0.3× 403 1.1× 402 1.5× 140 0.5× 63 3.0k
Nicola G. Wallis United Kingdom 23 908 0.5× 317 0.3× 249 0.7× 198 0.8× 101 0.4× 45 1.8k
Focco van den Akker United States 33 1.6k 1.0× 264 0.3× 208 0.5× 270 1.0× 380 1.5× 80 3.3k
Seiji Yamasaki Japan 32 1.4k 0.9× 258 0.3× 622 1.6× 151 0.6× 491 1.9× 124 3.4k
Johannes Zuegg Australia 27 1.3k 0.8× 651 0.7× 237 0.6× 171 0.7× 99 0.4× 54 2.4k
Fréderic Frézard Brazil 42 1.3k 0.8× 1.0k 1.1× 594 1.6× 157 0.6× 337 1.3× 152 4.5k

Countries citing papers authored by John R. Rubin

Since Specialization
Citations

This map shows the geographic impact of John R. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Rubin more than expected).

Fields of papers citing papers by John R. Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Rubin. The network helps show where John R. Rubin may publish in the future.

Co-authorship network of co-authors of John R. Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Rubin. A scholar is included among the top collaborators of John R. Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Rubin. John R. Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Chang Woo, Marie T. Krüger, Harith Akram, et al.. (2024). Central Mechanisms and Pathophysiology of Laryngeal Dystonia: An Up-to-Date Review. Journal of Voice. 1 indexed citations
2.
Ducci, Andrea, Ramanarayanan Balachandran, Liwei Guo, et al.. (2023). Response to: ‘Use of portable air purifiers to reduce aerosols in hospital settings and cut down the clinical backlog’. Epidemiology and Infection. 151. e87–e87. 1 indexed citations
3.
Tamura, Shuzo, Yin Wang, Brendan Veeneman, et al.. (2018). Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer. Bladder Cancer. 4(1). 77–90. 17 indexed citations
4.
Brown, William Clay, et al.. (2011). New ligation-independent cloning vectors compatible with a high-throughput platform for parallel construct expression evaluation using baculovirus-infected insect cells. Protein Expression and Purification. 77(1). 34–45. 12 indexed citations
5.
Galatsis, Paul, Bradley W. Caprathe, John L. Gilmore, et al.. (2010). Succinic acid amides as P2–P3 replacements for inhibitors of interleukin-1β converting enzyme (ICE or caspase 1). Bioorganic & Medicinal Chemistry Letters. 20(17). 5184–5190. 16 indexed citations
6.
Biswas, Tapan, Yi Li, Parag Aggarwal, et al.. (2009). The Tail of KdsC. Journal of Biological Chemistry. 284(44). 30594–30603. 17 indexed citations
7.
Bachand, Benoit, Lorraine Leblond, P.D. Winocour, et al.. (2001). Novel bicyclic lactam inhibitors of thrombin: potency and selectivity optimization through P1 residues. Bioorganic & Medicinal Chemistry Letters. 11(24). 3161–3164. 14 indexed citations
8.
Shahripour, Aurash, Mark S. Plummer, Elizabeth A. Lunney, et al.. (2001). Structure-based design of caspase-1 inhibitor containing a diphenyl ether sulfonamide. Bioorganic & Medicinal Chemistry Letters. 11(20). 2779–2782. 14 indexed citations
9.
Cody, Wayne L., et al.. (2000). Progress in the Development of Inhibitors of SH2 Domains. Current Pharmaceutical Design. 6(1). 59–98. 45 indexed citations
10.
Cody, Wayne L., Annette M. Doherty, Jeremy J. Edmunds, et al.. (1999). The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1. Bioorganic & Medicinal Chemistry Letters. 9(17). 2497–2502. 10 indexed citations
11.
Cody, Wayne L., Corinne E. Augelli‐Szafran, Annette M. Doherty, et al.. (1999). The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2. Bioorganic & Medicinal Chemistry Letters. 9(17). 2503–2508. 3 indexed citations
12.
13.
Heath, Richard J., et al.. (1999). Mechanism of Triclosan Inhibition of Bacterial Fatty Acid Synthesis. Journal of Biological Chemistry. 274(16). 11110–11114. 434 indexed citations
14.
Cody, Wayne L., John DiMaio, Annette M. Doherty, et al.. (1998). Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 Modifications. Bioorganic & Medicinal Chemistry Letters. 8(23). 3409–3414. 18 indexed citations
15.
Augelli‐Szafran, Corinne E., Benoit Bachand, John DiMaio, et al.. (1998). Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications. Bioorganic & Medicinal Chemistry Letters. 8(22). 3193–3198. 14 indexed citations
16.
Rubin, John R., et al.. (1992). Structure of the anti-malarial drug primaquine diphosphate. Acta Crystallographica Section C Crystal Structure Communications. 48(2). 379–382. 7 indexed citations
17.
Rubin, John R., et al.. (1991). Structure of the anti-cancer drug complex tetrakis(μ-acetato)-bis(1-methyladenosine)dirhodium(II) monohydrate. Acta Crystallographica Section C Crystal Structure Communications. 47(8). 1712–1714. 29 indexed citations
18.
Samudzi, Cleopas T., et al.. (1991). Crystallization and preliminary X-ray diffraction studies of recombinant rabbit interferon-gamma. Biochemical and Biophysical Research Communications. 178(2). 634–640. 3 indexed citations
19.
Rubin, John R. & M. Sundaralingam. (1984). Crosslinking of tRNAs by the Carcinostatic Agent Dirhodium Tetraacetate. Journal of Biomolecular Structure and Dynamics. 2(3). 525–530. 9 indexed citations
20.
Rubin, John R. & M. Sundaralingam. (1984). An Unexpected Major Groove Binding of Netropsin and Distamycin A to tRNAphe. Journal of Biomolecular Structure and Dynamics. 2(1). 165–174. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Rose Breakdown of academic impact, for papers by C T Walsh Breakdown of academic impact, for papers by Michael J. Kelso Breakdown of academic impact, for papers by Cai‐Guang Yang Breakdown of academic impact, for papers by Glenn E. Dale Breakdown of academic impact, for papers by Nicola G. Wallis Breakdown of academic impact, for papers by Focco van den Akker Breakdown of academic impact, for papers by Seiji Yamasaki Breakdown of academic impact, for papers by Johannes Zuegg Breakdown of academic impact, for papers by Fréderic Frézard
Rankless by CCL
2026